newsfilter
← Latest News
Business Wire·

Aptinyx to Participate in William Blair Biotech Focus Conference 2021

Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, today announced that Norbert Riedel, Ph.D., chief executive officer, will participate in the Update